PROSOMNUS INC (OSA) Stock Price, Forecast & Analysis
NASDAQ:OSA • US50535E1082
OSA Key Statistics, Chart & Performance
The current stock price of OSA is 0.47 USD. In the past month the price decreased by -29.09%. In the past year, price decreased by -90.8%.
OSA Technical Analysis
OSA Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to OSA. Both the profitability and financial health of OSA have multiple concerns.
OSA Financial Highlights
Over the last trailing twelve months OSA reported a non-GAAP Earnings per Share(EPS) of -0.94. The EPS decreased by -28.77% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -49.44% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
OSA Forecast & Estimates
7 analysts have analysed OSA and the average price target is 2.55 USD. This implies a price increase of 442.55% is expected in the next year compared to the current price of 0.47.
For the next year, analysts expect an EPS growth of -101.05% and a revenue growth 41.66% for OSA
OSA Ownership
OSA Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 19.66 | 195.206B | ||
| ISRG | INTUITIVE SURGICAL INC | 48.91 | 175.203B | ||
| SYK | STRYKER CORP | 24.61 | 141.182B | ||
| BSX | BOSTON SCIENTIFIC CORP | 21.64 | 113.14B | ||
| BDX | BECTON DICKINSON AND CO | 11.54 | 50.537B | ||
| IDXX | IDEXX LABORATORIES INC | 42.83 | 50B | ||
| EW | EDWARDS LIFESCIENCES CORP | 26.35 | 45.525B | ||
| RMD | RESMED INC | 21.01 | 37.268B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 16.42 | 37.194B | ||
| DXCM | DEXCOM INC | 28.81 | 27.469B |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About OSA
Company Profile
Prosomnus, Inc. is a medical technology company, which engages in the business of developing, manufacturing, and marketing precision intraoral medical devices. The company is headquartered in Pleasanton, California and currently employs 129 full-time employees. The company went IPO on 2021-06-15. The Company’s intraoral medical devices are engineered to track the treatment plan and anatomy of each patient. Its precision intraoral devices are Food and Drug Administration (FDA)-cleared, patented and covered by commercial medical insurance, Medicare, TRICARE and other Government-sponsored healthcare plans around the world, representing approximately 200 million covered lives. The Company’s products include ProSomnus EVO Sleep and Snore Device, ProSomnus EVO SELECT Sleep and Snore Device, ProSomnus EVO [PH] Sleep and Snore Device, ProSomnus [CA] LP Sleep and Snore Device and ProSomnus [MOG] Morning Occlusal Guide. The Company’s wholly owned subsidiaries include ProSomnus Holdings, Inc. and ProSomnus Sleep Technologies, Inc.
Company Info
PROSOMNUS INC
5675 Gibraltar Dr
Pleasanton CALIFORNIA US
Employees: 129
Phone: 18445375337
PROSOMNUS INC / OSA FAQ
What does OSA do?
Prosomnus, Inc. is a medical technology company, which engages in the business of developing, manufacturing, and marketing precision intraoral medical devices. The company is headquartered in Pleasanton, California and currently employs 129 full-time employees. The company went IPO on 2021-06-15. The Company’s intraoral medical devices are engineered to track the treatment plan and anatomy of each patient. Its precision intraoral devices are Food and Drug Administration (FDA)-cleared, patented and covered by commercial medical insurance, Medicare, TRICARE and other Government-sponsored healthcare plans around the world, representing approximately 200 million covered lives. The Company’s products include ProSomnus EVO Sleep and Snore Device, ProSomnus EVO SELECT Sleep and Snore Device, ProSomnus EVO [PH] Sleep and Snore Device, ProSomnus [CA] LP Sleep and Snore Device and ProSomnus [MOG] Morning Occlusal Guide. The Company’s wholly owned subsidiaries include ProSomnus Holdings, Inc. and ProSomnus Sleep Technologies, Inc.
Can you provide the latest stock price for PROSOMNUS INC?
The current stock price of OSA is 0.47 USD. The price decreased by -10.29% in the last trading session.
Does PROSOMNUS INC pay dividends?
OSA does not pay a dividend.
What is the ChartMill technical and fundamental rating of OSA stock?
OSA has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
Which stock exchange lists OSA stock?
OSA stock is listed on the Nasdaq exchange.
Is PROSOMNUS INC (OSA) stock a good buy?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on OSA.
Can you provide the growth outlook for PROSOMNUS INC?
The Revenue of PROSOMNUS INC (OSA) is expected to grow by 41.66% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.